{"id":67341,"date":"2026-06-04T20:53:33","date_gmt":"2026-06-04T12:53:33","guid":{"rendered":"https:\/\/flcube.com\/?p=67341"},"modified":"2026-06-04T20:53:34","modified_gmt":"2026-06-04T12:53:34","slug":"medtronic-makes-strategic-ice-catheter-investments-to-strengthen-cardiac-ablation-leadership-and-affera-ecosystem-integration","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=67341","title":{"rendered":"Medtronic Makes Strategic ICE Catheter Investments to Strengthen Cardiac Ablation Leadership and Affera Ecosystem Integration"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Medtronic plc<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/MDT:NYSE\">NYSE: MDT<\/a>) announced on <strong>June 3, 2026<\/strong>, strategic investments in two privately held companies developing <strong>intracardiac echocardiography (ICE) catheter technologies<\/strong>: <strong>Beluga Medical<\/strong>, a California-based premarket-stage innovator, and <strong>CardioACC<\/strong>, an early commercial-stage company headquartered in <strong>Shenzhen, China<\/strong>. The investments reinforce Medtronic&#8217;s momentum in cardiac ablation and support integration of ICE capabilities into the <strong>Affera mapping and ablation system<\/strong>.<\/p>\n\n\n\n<h2 id=\"h-investment-portfolio-amp-company-profiles\" class=\"wp-block-heading\">Investment Portfolio &amp; Company Profiles<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Portfolio Company<\/th><th>Stage<\/th><th>Location<\/th><th>Regulatory Status<\/th><th>Technology Focus<\/th><\/tr><\/thead><tbody><tr><td><strong>Beluga Medical<\/strong><\/td><td>Premarket<\/td><td>California, USA<\/td><td>Development phase<\/td><td>Next-generation ICE catheter<\/td><\/tr><tr><td><strong>CardioACC<\/strong><\/td><td>Early commercial<\/td><td>Shenzhen, China<\/td><td>NMPA approved (2025)<\/td><td>ICE imaging system<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Both companies specialize in ICE catheter technologies that provide <strong>real-time, high-resolution cardiac imaging<\/strong> during electrophysiology (EP) procedures for cardiac arrhythmias, particularly <strong>atrial fibrillation (Afib)<\/strong>.<\/p>\n\n\n\n<h2 id=\"h-strategic-rationale-amp-market-context\" class=\"wp-block-heading\">Strategic Rationale &amp; Market Context<\/h2>\n\n\n\n<h3 id=\"h-cardiac-ablation-business-momentum\" class=\"wp-block-heading\">Cardiac Ablation Business Momentum<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Recent Performance:<\/strong> Cardiac Ablation Solutions delivered 78% global growth in Q4 FY26<\/li>\n\n\n\n<li><strong>US Market Leadership:<\/strong> 124% US growth reflects strong adoption of next-generation ablation technologies<\/li>\n\n\n\n<li><strong>Technology Gap:<\/strong> ICE imaging represents critical missing component in comprehensive EP lab solutions<\/li>\n\n\n\n<li><strong>Competitive Pressure:<\/strong> Rivals offering integrated ICE capabilities creating market differentiation<\/li>\n<\/ul>\n\n\n\n<h3 id=\"h-intracardiac-echocardiography-ice-market-dynamics\" class=\"wp-block-heading\">Intracardiac Echocardiography (ICE) Market Dynamics<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Clinical Value:<\/strong> Real-time visualization enables precise catheter navigation and tissue contact assessment<\/li>\n\n\n\n<li><strong>Procedural Safety:<\/strong> Reduces complications through continuous monitoring of cardiac structures<\/li>\n\n\n\n<li><strong>Workflow Efficiency:<\/strong> Eliminates need for transesophageal echocardiography (TEE) in many procedures<\/li>\n\n\n\n<li><strong>Market Adoption:<\/strong> Growing standard of care in complex EP procedures, particularly Afib ablation<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-affera-ecosystem-integration-strategy\" class=\"wp-block-heading\">Affera Ecosystem Integration Strategy<\/h2>\n\n\n\n<h3 id=\"h-current-affera-platform-capabilities\" class=\"wp-block-heading\">Current Affera Platform Capabilities<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Mapping System:<\/strong> High-density electroanatomic mapping for complex arrhythmias<\/li>\n\n\n\n<li><strong>Ablation Technologies:<\/strong> Multi-energy source ablation with advanced lesion formation monitoring<\/li>\n\n\n\n<li><strong>Workflow Integration:<\/strong> Seamless procedural workflow from diagnosis to treatment<\/li>\n<\/ul>\n\n\n\n<h3 id=\"h-ice-integration-benefits\" class=\"wp-block-heading\">ICE Integration Benefits<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Comprehensive Solution:<\/strong> Creates end-to-end EP lab platform with integrated imaging<\/li>\n\n\n\n<li><strong>Differentiated Value Proposition:<\/strong> Addresses key unmet need for real-time intracardiac visualization<\/li>\n\n\n\n<li><strong>Cross-Selling Opportunities:<\/strong> Leverages existing Affera customer base for ICE adoption<\/li>\n\n\n\n<li><strong>Revenue Synergies:<\/strong> Higher procedure volumes and premium pricing for integrated solutions<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-geographic-amp-regulatory-advantages\" class=\"wp-block-heading\">Geographic &amp; Regulatory Advantages<\/h2>\n\n\n\n<h3 id=\"h-cardioacc-strategic-value\" class=\"wp-block-heading\">CardioACC Strategic Value<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>NMPA Approval:<\/strong> Already cleared for commercial use in China (2025)<\/li>\n\n\n\n<li><strong>Asia-Pacific Expansion:<\/strong> Provides immediate entry into growing Chinese EP market<\/li>\n\n\n\n<li><strong>Local Manufacturing:<\/strong> Potential cost advantages and supply chain resilience<\/li>\n\n\n\n<li><strong>Regulatory Pathway:<\/strong> Chinese approval may support expedited pathways in other markets<\/li>\n<\/ul>\n\n\n\n<h3 id=\"h-beluga-medical-innovation-potential\" class=\"wp-block-heading\">Beluga Medical Innovation Potential<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Next-Generation Technology:<\/strong> Advanced imaging capabilities beyond current ICE standards<\/li>\n\n\n\n<li><strong>US Development:<\/strong> Aligns with Medtronic&#8217;s domestic innovation strategy<\/li>\n\n\n\n<li><strong>IP Portfolio:<\/strong> Potential for novel intellectual property in ICE catheter design<\/li>\n\n\n\n<li><strong>Technical Synergies:<\/strong> Complements existing Medtronic imaging and catheter expertise<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-financial-amp-competitive-implications\" class=\"wp-block-heading\">Financial &amp; Competitive Implications<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Investment Scale:<\/strong> Undisclosed amounts reflect strategic rather than controlling investments<\/li>\n\n\n\n<li><strong>Risk Mitigation:<\/strong> Dual investment approach diversifies technology and regulatory risk<\/li>\n\n\n\n<li><strong>Time-to-Market:<\/strong> CardioACC provides near-term commercial capability while Beluga offers long-term innovation<\/li>\n\n\n\n<li><strong>Ecosystem Lock-in:<\/strong> Integrated ICE solution strengthens Affera platform defensibility against competitors<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">The strategic investments demonstrate Medtronic&#8217;s commitment to building a comprehensive, differentiated EP portfolio that addresses the full spectrum of clinical needs in cardiac ablation procedures.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward-looking statements regarding investment outcomes, technology integration timelines, and market opportunities. Actual results may differ materially due to regulatory approvals, competitive dynamics, technology development challenges, and market adoption rates.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Medtronic plc (NYSE: MDT) announced on June 3, 2026, strategic investments in two privately held&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10,22],"tags":[233,1031],"class_list":["post-67341","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","category-medical-device","tag-medtronic","tag-nyse-mdt"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v27.7) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Medtronic Makes Strategic ICE Catheter Investments to Strengthen Cardiac Ablation Leadership and Affera Ecosystem Integration - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Medtronic plc (NYSE: MDT) announced on June 3, 2026, strategic investments in two privately held companies developing intracardiac echocardiography (ICE) catheter technologies: Beluga Medical, a California-based premarket-stage innovator, and CardioACC, an early commercial-stage company headquartered in Shenzhen, China. The investments reinforce Medtronic&#039;s momentum in cardiac ablation and support integration of ICE capabilities into the Affera mapping and ablation system.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=67341\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Medtronic Makes Strategic ICE Catheter Investments to Strengthen Cardiac Ablation Leadership and Affera Ecosystem Integration\" \/>\n<meta property=\"og:description\" content=\"Medtronic plc (NYSE: MDT) announced on June 3, 2026, strategic investments in two privately held companies developing intracardiac echocardiography (ICE) catheter technologies: Beluga Medical, a California-based premarket-stage innovator, and CardioACC, an early commercial-stage company headquartered in Shenzhen, China. The investments reinforce Medtronic&#039;s momentum in cardiac ablation and support integration of ICE capabilities into the Affera mapping and ablation system.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=67341\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-04T12:53:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-04T12:53:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67341#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67341\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Medtronic Makes Strategic ICE Catheter Investments to Strengthen Cardiac Ablation Leadership and Affera Ecosystem Integration\",\"datePublished\":\"2026-06-04T12:53:33+00:00\",\"dateModified\":\"2026-06-04T12:53:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67341\"},\"wordCount\":515,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"Medtronic\",\"NYSE: MDT\"],\"articleSection\":[\"Company\",\"Deals\",\"Medical Device\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=67341#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67341\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=67341\",\"name\":\"Medtronic Makes Strategic ICE Catheter Investments to Strengthen Cardiac Ablation Leadership and Affera Ecosystem Integration - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-06-04T12:53:33+00:00\",\"dateModified\":\"2026-06-04T12:53:34+00:00\",\"description\":\"Medtronic plc (NYSE: MDT) announced on June 3, 2026, strategic investments in two privately held companies developing intracardiac echocardiography (ICE) catheter technologies: Beluga Medical, a California-based premarket-stage innovator, and CardioACC, an early commercial-stage company headquartered in Shenzhen, China. The investments reinforce Medtronic's momentum in cardiac ablation and support integration of ICE capabilities into the Affera mapping and ablation system.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67341#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=67341\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67341#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Medtronic Makes Strategic ICE Catheter Investments to Strengthen Cardiac Ablation Leadership and Affera Ecosystem Integration\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Medtronic Makes Strategic ICE Catheter Investments to Strengthen Cardiac Ablation Leadership and Affera Ecosystem Integration - Insight, China&#039;s Pharmaceutical Industry","description":"Medtronic plc (NYSE: MDT) announced on June 3, 2026, strategic investments in two privately held companies developing intracardiac echocardiography (ICE) catheter technologies: Beluga Medical, a California-based premarket-stage innovator, and CardioACC, an early commercial-stage company headquartered in Shenzhen, China. The investments reinforce Medtronic's momentum in cardiac ablation and support integration of ICE capabilities into the Affera mapping and ablation system.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=67341","og_locale":"en_US","og_type":"article","og_title":"Medtronic Makes Strategic ICE Catheter Investments to Strengthen Cardiac Ablation Leadership and Affera Ecosystem Integration","og_description":"Medtronic plc (NYSE: MDT) announced on June 3, 2026, strategic investments in two privately held companies developing intracardiac echocardiography (ICE) catheter technologies: Beluga Medical, a California-based premarket-stage innovator, and CardioACC, an early commercial-stage company headquartered in Shenzhen, China. The investments reinforce Medtronic's momentum in cardiac ablation and support integration of ICE capabilities into the Affera mapping and ablation system.","og_url":"https:\/\/flcube.com\/?p=67341","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-06-04T12:53:33+00:00","article_modified_time":"2026-06-04T12:53:34+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=67341#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=67341"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Medtronic Makes Strategic ICE Catheter Investments to Strengthen Cardiac Ablation Leadership and Affera Ecosystem Integration","datePublished":"2026-06-04T12:53:33+00:00","dateModified":"2026-06-04T12:53:34+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=67341"},"wordCount":515,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["Medtronic","NYSE: MDT"],"articleSection":["Company","Deals","Medical Device"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=67341#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=67341","url":"https:\/\/flcube.com\/?p=67341","name":"Medtronic Makes Strategic ICE Catheter Investments to Strengthen Cardiac Ablation Leadership and Affera Ecosystem Integration - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-06-04T12:53:33+00:00","dateModified":"2026-06-04T12:53:34+00:00","description":"Medtronic plc (NYSE: MDT) announced on June 3, 2026, strategic investments in two privately held companies developing intracardiac echocardiography (ICE) catheter technologies: Beluga Medical, a California-based premarket-stage innovator, and CardioACC, an early commercial-stage company headquartered in Shenzhen, China. The investments reinforce Medtronic's momentum in cardiac ablation and support integration of ICE capabilities into the Affera mapping and ablation system.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=67341#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=67341"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=67341#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Medtronic Makes Strategic ICE Catheter Investments to Strengthen Cardiac Ablation Leadership and Affera Ecosystem Integration"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/67341","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=67341"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/67341\/revisions"}],"predecessor-version":[{"id":67343,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/67341\/revisions\/67343"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=67341"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=67341"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=67341"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}